4/7
08:06 pm
nbix
Neurocrine to acquire Soleno in $2.9bn transaction [Yahoo! Finance]
Low
Report
Neurocrine to acquire Soleno in $2.9bn transaction [Yahoo! Finance]
4/7
06:33 pm
nbix
Assessing Neurocrine Biosciences (NBIX) Valuation As Long Term Returns Outpace A Richer Earnings Multiple [Yahoo! Finance]
Low
Report
Assessing Neurocrine Biosciences (NBIX) Valuation As Long Term Returns Outpace A Richer Earnings Multiple [Yahoo! Finance]
4/7
02:33 pm
nbix
Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $204.00 to $242.00. They now have a "buy" rating on the stock.
Low
Report
Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $204.00 to $242.00. They now have a "buy" rating on the stock.
4/7
10:52 am
nbix
Neurocrine Biosciences (NBIX) had its price target raised by Canaccord Genuity Group Inc. from $164.00 to $200.00. They now have a "buy" rating on the stock.
Low
Report
Neurocrine Biosciences (NBIX) had its price target raised by Canaccord Genuity Group Inc. from $164.00 to $200.00. They now have a "buy" rating on the stock.
4/7
08:55 am
nbix
Neurocrine Biosciences (NBIX) had its price target raised by Wedbush from $151.00 to $166.00. They now have an "outperform" rating on the stock.
Low
Report
Neurocrine Biosciences (NBIX) had its price target raised by Wedbush from $151.00 to $166.00. They now have an "outperform" rating on the stock.
4/7
08:02 am
nbix
Neurocrine Biosciences (NBIX) had its price target raised by HC Wainwright from $192.00 to $215.00. They now have a "buy" rating on the stock.
Low
Report
Neurocrine Biosciences (NBIX) had its price target raised by HC Wainwright from $192.00 to $215.00. They now have a "buy" rating on the stock.
4/6
06:11 pm
nbix
Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement [Globe and Mail, The (Toronto, Canada)]
Low
Report
Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement [Globe and Mail, The (Toronto, Canada)]
4/6
04:49 pm
nbix
Why Soleno Therapeutics Stock Rocketed Higher on Monday [Yahoo! Finance]
Low
Report
Why Soleno Therapeutics Stock Rocketed Higher on Monday [Yahoo! Finance]
4/6
12:54 pm
nbix
Neurocrine Biosciences (NBIX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $185.00 price target on the stock.
Low
Report
Neurocrine Biosciences (NBIX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $185.00 price target on the stock.
4/6
12:27 pm
nbix
Neurocrine Biosciences Details $2.9B Soleno Buyout, Touts Vykat XR as Potential Blockbuster [Yahoo! Finance]
Low
Report
Neurocrine Biosciences Details $2.9B Soleno Buyout, Touts Vykat XR as Potential Blockbuster [Yahoo! Finance]
4/6
11:37 am
nbix
Neurocrine Biosciences, Inc. (NBIX) M&A Call Transcript [Seeking Alpha]
Low
Report
Neurocrine Biosciences, Inc. (NBIX) M&A Call Transcript [Seeking Alpha]
4/6
10:58 am
nbix
Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyout [Yahoo! Finance]
Low
Report
Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyout [Yahoo! Finance]
4/6
09:57 am
nbix
Neurocrine Biosciences to acquire Soleno Therapeutics in $2.9B deal [Yahoo! Finance]
Medium
Report
Neurocrine Biosciences to acquire Soleno Therapeutics in $2.9B deal [Yahoo! Finance]
4/6
09:18 am
nbix
Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal [Yahoo! Finance]
Low
Report
Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal [Yahoo! Finance]
4/6
08:59 am
nbix
SLNO Jumps As Deal Buzz Lifts Stocks [Yahoo! Finance]
Low
Report
SLNO Jumps As Deal Buzz Lifts Stocks [Yahoo! Finance]
4/6
08:51 am
nbix
Neurocrine to Buy Soleno for $2.9 Billion [Yahoo! Finance]
Low
Report
Neurocrine to Buy Soleno for $2.9 Billion [Yahoo! Finance]
4/6
07:19 am
nbix
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio [Yahoo! Finance]
Medium
Report
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio [Yahoo! Finance]
4/6
07:17 am
nbix
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio [TheStreet.com]
Medium
Report
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio [TheStreet.com]
4/6
07:00 am
nbix
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Low
Report
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
4/6
04:55 am
nbix
Soleno Therapeutics rallies on report of $2.5B Neurocrine buyout talks [Seeking Alpha]
Low
Report
Soleno Therapeutics rallies on report of $2.5B Neurocrine buyout talks [Seeking Alpha]
3/27
01:18 am
nbix
Is Geriatric-Focused INGREZZA Data Quietly Reframing Neurocrine Biosciences' Neurology Leadership Narrative (NBIX)? [Yahoo! Finance]
Medium
Report
Is Geriatric-Focused INGREZZA Data Quietly Reframing Neurocrine Biosciences' Neurology Leadership Narrative (NBIX)? [Yahoo! Finance]
3/26
08:49 am
nbix
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings [Yahoo! Finance]
Neutral
Report
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings [Yahoo! Finance]
3/26
08:30 am
nbix
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Low
Report
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
3/23
11:46 am
nbix
Biocom Appoints New Members to Its Board of Directors [Yahoo! Finance]
Low
Report
Biocom Appoints New Members to Its Board of Directors [Yahoo! Finance]
3/17
04:37 pm
nbix
Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer [Yahoo! Finance]
Low
Report
Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer [Yahoo! Finance]